Developing stable mRNA vaccines using deep learning techniques
A deep learning and experiment integrated platform for stable mRNA vaccines development
['FUNDING_R01'] · TEXAS ENGINEERING EXPERIMENT STATION · NIH-10974030
This study is working on making COVID-19 mRNA vaccines better by figuring out how to keep them stable, so they can be stored and transported more easily, which could help more people get vaccinated.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS ENGINEERING EXPERIMENT STATION (nih funded) |
| Locations | 1 site (COLLEGE STATION, UNITED STATES) |
| Trial ID | NIH-10974030 on ClinicalTrials.gov |
What this research studies
This research focuses on improving mRNA vaccines, particularly for COVID-19, by addressing their stability issues. Researchers will use deep learning methods to predict which mRNA sequences are most stable and less prone to degradation. By combining computational models with experimental validation, the team aims to create mRNA vaccines that can be stored and transported without stringent cold chain requirements. This innovative approach could lead to more effective and accessible vaccines for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from more stable and accessible COVID-19 vaccines.
Not a fit: Patients who are not affected by COVID-19 or do not require vaccination may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of mRNA vaccines that are easier to store and transport, improving vaccination efforts worldwide.
How similar studies have performed: Other research has shown promise in using deep learning for biological applications, suggesting potential success for this novel approach.
Where this research is happening
COLLEGE STATION, UNITED STATES
- TEXAS ENGINEERING EXPERIMENT STATION — COLLEGE STATION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SUN, QING — TEXAS ENGINEERING EXPERIMENT STATION
- Study coordinator: SUN, QING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, coronavirus disease 2019, coronavirus disease 2019 vaccine, coronavirus disease-19